<DOC>
	<DOCNO>NCT00796198</DOCNO>
	<brief_summary>Hypothesis : Studies suggest patient low diastolic velocity high resistivity index ophthalmic artery progressive visual field , investigator hypothesize therefore addition Cosopt Latanoprost could improve ocular diastolic perfusion pressure ( ODPP ) . Objective : To evaluate effect Cosopt ODPP patient adequately control latanoprost alone .</brief_summary>
	<brief_title>Effects Cosopt IOP Ocular Diastolic Perfusion Pressure</brief_title>
	<detailed_description>Fifty patient primary open angle glaucoma ( POAG ) treat Xalatan monotherapy sufficient achieve target IOP , include study . Non responder define IOP &gt; 20 mmHg IOP reduction le 25 % baseline IOP . Patients classify POAG typical glaucomatous visual field and/or typical abnormal optic nerve head , open angle gonioscopy , IOP &gt; 21 mmHg treatment clinically apparent secondary cause glaucoma ( EGS guideline ) . Visual field assess Humphrey Field Analyzer 750 ( HFA , Humphrey , Inc , CA , USA ) , 24-2 SITA ( Swedish Interactive Threshold Algorithm ) standard . A glaucomatous visual field defect define : 1 ) three adjacent point depress 5 dB , one point depress least 10 dB ; 2 ) two adjacent point depress 10 dB ; 3 ) 10 dB difference across nasal horizontal meridian two adjacent point . None point could edge point unless immediately nasal horizontal meridian . In addition , visual field test consider reliable false-negative response less 30 % fixation loss less 20 % HFA . The abnormal optic nerve head classification base presence optic rim notch diffuse / generalize loss optic rim tissue , vertical cup/disc diameter ratio asymmetry unexplained side difference optic disc size , disc haemorrhage . In centre , patient 's recruitment start soon ethical committee approve protocol . Each sit recruit 10 patient ( 5 + 5 ) . Cosopt add Xalatan Xalatan effective sufficient reach target pressure ( Add group ) ( n = 25 ) , Xalatan effective sufficient reach target pressure medication add ( control group ) ( n = 25 ) . ( EGS guideline : Target pressure subjective value none able ass ( ! ) . Efficacy drug : medication decrease IOP describe phase three clinical trial . Not sufficient : medication effective able reach target IOP . ) Each patient submit three different visit : - Baseline visit : Systemic Pressure , IOP , VF , HRF , Visual Acuity , ophthalmic examination corneal central thickness ( CCT ) - Visit 1 month : Systemic Pressure , IOP , Visual Acuity , ophthalmic examination - Visit 3 month : Systemic Pressure , IOP , HRF , Visual Acuity , ophthalmic examination ( + CCT ) ODPP calculate : `` systemic diastolic pressure - IOP '' session .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>POAG patient pattern deviation score ( equivalent ) range 2.5 dB 6.0 dB include study . This ensure patient early/midstage glaucoma homogeneously collect ; avoids advance glaucoma OBF may behave different disease state . Bestcorrected visual acuity 0.5 good ametropia &lt; 5D Dioptric transparency , non smoker . Age 45 65 year . n Normal tension glaucoma , ocular hypertension , cardiovascular and/or metabolic disease ( know affect blood flow , diabetes polycythemia ) Visual field defect glaucoma ; use vasoactive and/or antihypertensive drug ( systemic betablocker ) , use acetazolamide Hypersensibility and/or contraindication molecule study Previous ocular surgery Pregnant nursing woman use one drug erectile dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>Intraocular pressure</keyword>
	<keyword>Ocular diastolic perfusion pressure</keyword>
	<keyword>Dorzolamide/timolol Fixed combination</keyword>
	<keyword>Heidelberg Retina Flowmeter</keyword>
</DOC>